Cite
Phase II trial of paclitaxel, carboplatin, and topotecan with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: Southwest Oncology Group 9914.
MLA
Hesketh, Paul J., et al. “Phase II Trial of Paclitaxel, Carboplatin, and Topotecan with G-CSF Support in Previously Untreated Patients with Extensive Stage Small Cell Lung Cancer: Southwest Oncology Group 9914.” Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer, vol. 1, no. 9, Nov. 2006, pp. 991–95. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=17409984&authtype=sso&custid=ns315887.
APA
Hesketh, P. J., McCoy, J., Dunphy, F. R., 2nd, Bearden, J. D., 3rd, Weiss, G. R., Giguere, J. K., Atkins, J. N., Dakhil, S. R., Kelly, K., Crowley, J. J., & Gandara, D. R. (2006). Phase II trial of paclitaxel, carboplatin, and topotecan with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: Southwest Oncology Group 9914. Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer, 1(9), 991–995.
Chicago
Hesketh, Paul J, Jason McCoy, Frank R Dunphy 2nd, James D Bearden 3rd, Geoffrey R Weiss, Jeffrey K Giguere, James N Atkins, et al. 2006. “Phase II Trial of Paclitaxel, Carboplatin, and Topotecan with G-CSF Support in Previously Untreated Patients with Extensive Stage Small Cell Lung Cancer: Southwest Oncology Group 9914.” Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer 1 (9): 991–95. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=17409984&authtype=sso&custid=ns315887.